Who is the CEO of Dentis?

According to the DART company overview, Dentis' representative director is 심기봉 (name as registered in Korean). The company was founded on 2016-12-01.

Where is Dentis listed?

Dentis trades on the Korea Exchange KOSDAQ market under the ticker 261200. Its fiscal year ends in December.

Does Dentis pay a dividend?

Dentis did not pay a cash dividend for fiscal 2025, according to its annual report.

Does Dentis have any recent filing signals?

Signals detected automatically from DART filings and quarterly results: Share pledge (a 5%+ holder reported a share pledge agreement (loan, extension or change) in the past 90 days); Turnaround (latest quarter swung to an operating profit from a loss a year earlier); Control change (change of largest shareholder, or a contract that would cause one (90 days)). These are factual flags, not investment advice.

Which companies are in the same industry as Dentis?

Under the Korean Standard Industrial Classification recorded on DART, Dentis is grouped with 72 other listed companies in medical devices. The most covered in Korean news over the past 30 days are CG MedTech, Seers and Sky Labs.

Dentis KRX:261200KOSDAQ

덴티스 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days0

DART filings, 7 days0

Articles tracked19since Sep 11

In Q2 2026, Dentis reported revenue of ₩32.1bn, down 0.8% year on year, and operating profit of ₩2.6bn. Dentis (덴티스) appeared in 0 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 21 with 5 articles. It was most often mentioned alongside Seoul Broadcasting System.

Filing signals Turnaround Control change Share pledge Screener

Dentis quarterly results consolidated, KRW

Quarter	Revenue	YoY	Operating profit	Net income
Q2 2026	₩32.1bn	-0.8%	₩2.6bn margin 8.2%	₩3.8bn
Q1 2026	₩30.2bn	-7.0%	₩3.1bn margin 10.1%	₩5.9bn
Q4 2025 derived	₩22.8bn	-11.2%	−₩9.6bn margin −42.0%	−₩8.7bn
Q3 2025	₩26.6bn	-10.5%	−₩1.6bn margin −5.9%	−₩1.3bn
Q2 2025	₩32.4bn	+6.7%	−₩308m margin −1.0%	−₩5.9bn
Q1 2025	₩32.5bn	+13.7%	₩1.0bn margin 3.2%	−₩528m
Q4 2024 derived	₩25.6bn	+22.8%	−₩5.4bn margin −21.0%	−₩1.4bn
Q3 2024	₩29.7bn	+15.4%	₩1.5bn margin 5.1%	−₩3.0bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Dentis top stories 2 weeks, by number of outlets

1
덴티스, SBS 드라마 '닥터X'에 주요 제품 협찬
2 outlets · 3 articlesFirst report Oct 21 11:06 이데일리Seoul Broadcasting System
2
덴티스, 드라마 ‘닥터X’에 루비스 수술등 협찬
2 outlets · 2 articlesFirst report Oct 21 10:44 메디포뉴스

Latest Dentis news Korean headlines

Oct 2111:08
덴티스, SBS 드라마 '닥터X'에 주요 제품 협찬
이데일리Seoul Broadcasting System
2 more on this story · 2 outlets
- 덴티스, SBS 드라마 '닥터X'에 주요 제품 협찬이데일리 · Oct 21 11:06
- 덴티스, SBS 드라마 '닥터X'에 주요 제품 협찬이데일리증권 · Oct 21 11:06
Oct 2110:44
덴티스, 드라마 ‘닥터X’에 루비스 수술등 협찬
메디포뉴스
1 more on this story · 1 outlets
- 덴티스, SBS 드라마 '닥터X'에 루비스 수술등 협찬핀포인트뉴스 · Oct 21 13:29
Oct 1418:24

Major[공시] 덴티스 불성실공시법인미지정 (지정유예)
스페셜타임스Negative news
Oct 614:24

Major덴티스, ‘루이버튼’ 임상 결과 국제학술지 게재…봉합시간 5분의 1로
브릿지경제Clinical trial
Oct 609:39
Major덴티스 ‘루이버튼’, RCT 임상 결과 세계적 치주학술지 JCP 게재
뉴스타운Clinical trial
1 more on this story · 1 outlets
- 덴티스, '루이버튼' RCT 임상 결과 국제학술지 게재뉴스핌 · Oct 6 15:06
Oct 609:08

덴티스 '루이버튼', RCT서 각화치은 감소 억제 확인
메디파나뉴스
Oct 608:46
Major덴티스 ‘루이버튼’, 임플란트 봉합시간 약 5배 단축…국제학술지 게재
중앙이코노미뉴스New technology
3 more on this story · 2 outlets
- 덴티스 "‘루이버튼’ 임상 결과 국제학술지 게재…봉합시간 78% 단축"이데일리증권 · Oct 6 17:33
- 덴티스 "‘루이버튼’ 임상 결과 국제학술지 게재…봉합시간 78% 단축"이데일리 · Oct 6 17:33
- 덴티스 "‘루이버튼’ 임상 결과 국제학술지 게재…봉합시간 78% 단축"이데일리 · Oct 6 17:35
Sep 1716:50

덴티스, 100억대 영업손실 속 자금 조달 의존 심화…공시 정정·불성실 공시 '경고음'
데일리연합
Sep 1620:43

Major[공시] 덴티스 불성실공시법인지정예고 (공시불이행 3건)
스페셜타임스Negative news
Sep 1517:00

Major덴티스 ‘AXEL’, 독일 CIF ‘TRUSTED QUALITY’ 인증 획득
바이오타임즈Certification
Sep 1509:24
Major덴티스, 독일 클린임플란트재단 인증 획득
핀포인트뉴스Certification
1 more on this story · 1 outlets
- 덴티스 'AXEL', 독일 클린임플란트 품질 인증 획득메디파나뉴스 · Sep 15 09:33

Articles per day 2 weeks

521

Company profile

CEO: 심기봉
Industry: Medical devices
Founded: 2016-12-01
Fiscal year-end: December
Head office: 대구광역시 달서구
Website: dentis.co.kr
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Major shareholders latest 5%+ report per holder

Korea 5% stake disclosures

심기봉28.71%
수성자산운용8.40%

Each holder's most recent 5% ownership report on DART; names as filed in Korean.

Same industry Medical devices

All in industry

Company	Latest quarter op. profit	Articles 30d
CG MedTech	₩333m	82
Seers	₩12.9bn	76
Sky Labs	–	71
Medyssey	–	47
Classys	₩43.9bn	43
Won Tech	₩11.1bn	42
Dio	₩4.4bn	36
InBody	₩17.7bn	29

Compare Dentis side by side with these companies

Dentis DART filings

Oct 1418:05

Other 불성실공시법인미지정 (지정유예)
Other
Sep 1618:17

Other 불성실공시법인지정예고 (공시불이행 3건)
Other
Sep 1617:00

5% ownership report 주식등의대량보유상황보고서(일반)
Ownership reports
Sep 1616:59

Change of largest shareholder [기재정정]최대주주변경을수반하는주식담보제공계약체결
Capital & M&A

Mentioned alongside 2 weeks

1 Seoul Broadcasting SystemKOSPI 4

Dentis FAQ

Who is the CEO of Dentis?: According to the DART company overview, Dentis' representative director is 심기봉 (name as registered in Korean). The company was founded on 2016-12-01.
Where is Dentis listed?: Dentis trades on the Korea Exchange KOSDAQ market under the ticker 261200. Its fiscal year ends in December.
What were Dentis' latest quarterly results?: In Q2 2026, Dentis reported revenue of ₩32.1bn, down 0.8% year on year, and operating profit of ₩2.6bn. Figures come from reports filed on DART.
Does Dentis pay a dividend?: Dentis did not pay a cash dividend for fiscal 2025, according to its annual report.
Does Dentis have any recent filing signals?: Signals detected automatically from DART filings and quarterly results: Share pledge (a 5%+ holder reported a share pledge agreement (loan, extension or change) in the past 90 days); Turnaround (latest quarter swung to an operating profit from a loss a year earlier); Control change (change of largest shareholder, or a contract that would cause one (90 days)). These are factual flags, not investment advice.
Which companies are in the same industry as Dentis?: Under the Korean Standard Industrial Classification recorded on DART, Dentis is grouped with 72 other listed companies in medical devices. The most covered in Korean news over the past 30 days are CG MedTech, Seers and Sky Labs.